<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>PR Hub &#187; Staines</title>
	<atom:link href="http://pr.gaeatimes.com/t/staines/feed/" rel="self" type="application/rss+xml" />
	<link>http://pr.gaeatimes.com</link>
	<description></description>
	<pubDate>Fri, 04 Nov 2011 09:16:53 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Astellas Pharma Europe Ltd Wins Scrip Award for Licensing Deal of the Year</title>
		<link>http://pr.gaeatimes.com/astellas-pharma-europe-ltd-wins-scrip-award-for-licensing-deal-of-the-year-52923/</link>
		<comments>http://pr.gaeatimes.com/astellas-pharma-europe-ltd-wins-scrip-award-for-licensing-deal-of-the-year-52923/#comments</comments>
		<pubDate>Fri, 04 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Ltd.</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Licensing / Marketing Agreements]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe Ltd.]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[November 4]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/astellas-pharma-europe-ltd-wins-scrip-award-for-licensing-deal-of-the-year-52923/</guid>
		<description><![CDATA[STAINES, England, November 4, 2011  -

Astellas Pharma Europe Ltd., is pleased to announce it is the proud recipient of the Scrip Award for Licensing Deal of the Year at the 7th Annual Scrip Awards ceremony, which took place last night at London&#8217;s Grosvenor House Hotel. Astellas Pharma Europe Ltd., which has 21 Sales Affiliates across Europe, ... Read more <a href="http://pr.gaeatimes.com/astellas-pharma-europe-ltd-wins-scrip-award-for-licensing-deal-of-the-year-52923/" title="Astellas Pharma Europe Ltd Wins Scrip Award for Licensing Deal of the Year">&raquo;&raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-pharma-europe-ltd-wins-scrip-award-for-licensing-deal-of-the-year-52923/feed/</wfw:commentRss>
		</item>
		<item>
		<title>World-leading Biomedical Engineer, Dr Robert Langer, Receives Economist Innovation Award for Bioscience Sponsored by Astellas Pharma Europe Ltd.</title>
		<link>http://pr.gaeatimes.com/world-leading-biomedical-engineer-dr-robert-langer-receives-economist-innovation-award-for-bioscience-sponsored-by-astellas-pharma-europe-ltd-52258/</link>
		<comments>http://pr.gaeatimes.com/world-leading-biomedical-engineer-dr-robert-langer-receives-economist-innovation-award-for-bioscience-sponsored-by-astellas-pharma-europe-ltd-52258/#comments</comments>
		<pubDate>Fri, 21 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Media]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[October 21]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/world-leading-biomedical-engineer-dr-robert-langer-receives-economist-innovation-award-for-bioscience-sponsored-by-astellas-pharma-europe-ltd-52258/</guid>
		<description><![CDATA[STAINES, England, October 21, 2011  -

?Astellas Pharma Europe Ltd. today presented The Economist Innovation 2011 award for Bioscience to one of the world&#8217;s most influential biomedical engineers, Dr Robert Langer &#8211; the man responsible for founding the field of controlled-release drug delivery and tissue engineering.
To view the Multimedia News Release, please click:
multivu.prnewswire.com/mnr/prne/astellaspharma/52158
This year marked the 10th ... <a href="http://pr.gaeatimes.com/world-leading-biomedical-engineer-dr-robert-langer-receives-economist-innovation-award-for-bioscience-sponsored-by-astellas-pharma-europe-ltd-52258/">Read this article on Gaea Times at  : World-leading Biomedical Engineer, Dr Robert Langer, Receives Economist Innovation Award for Bioscience Sponsored by Astellas Pharma Europe Ltd.</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/world-leading-biomedical-engineer-dr-robert-langer-receives-economist-innovation-award-for-bioscience-sponsored-by-astellas-pharma-europe-ltd-52258/feed/</wfw:commentRss>
		</item>
		<item>
		<title>CHMP Recommends Astellas Pharma Europe Ltd.&apos;s (APEL) DIFICLIR™ for Approval in the EU</title>
		<link>http://pr.gaeatimes.com/chmp-recommends-astellas-pharma-europe-ltds-apel-dificlir%e2%84%a2-for-approval-in-the-eu-50835/</link>
		<comments>http://pr.gaeatimes.com/chmp-recommends-astellas-pharma-europe-ltds-apel-dificlir%e2%84%a2-for-approval-in-the-eu-50835/#comments</comments>
		<pubDate>Fri, 23 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Limited</dc:creator>
		
		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Mobile Entertainment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Astellas Pharma Europe Limited]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[England And San Diego]]></category>

		<category><![CDATA[September 23]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/chmp-recommends-astellas-pharma-europe-ltds-apel-dificlir%e2%84%a2-for-approval-in-the-eu-50835/</guid>
		<description><![CDATA[STAINES, England and SAN DIEGO, California, September 23, 2011  -

Astellas Pharma Europe Ltd. (APEL) and Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for DIFICLIR&#8482; (fidaxomicin) tablets for the treatment of adults suffering with ... Read more <a href="http://pr.gaeatimes.com/chmp-recommends-astellas-pharma-europe-ltds-apel-dificlir%e2%84%a2-for-approval-in-the-eu-50835/" title="CHMP Recommends Astellas Pharma Europe Ltd.&apos;s (APEL) DIFICLIR™ for Approval in the EU">&raquo;&raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/chmp-recommends-astellas-pharma-europe-ltds-apel-dificlir%e2%84%a2-for-approval-in-the-eu-50835/feed/</wfw:commentRss>
		</item>
		<item>
		<title>International Photographic Exhibition Highlighting Patient Burden of Neuropathic Pain Opens at Scientific Conference</title>
		<link>http://pr.gaeatimes.com/international-photographic-exhibition-highlighting-patient-burden-of-neuropathic-pain-opens-at-scientific-conference-50701/</link>
		<comments>http://pr.gaeatimes.com/international-photographic-exhibition-highlighting-patient-burden-of-neuropathic-pain-opens-at-scientific-conference-50701/#comments</comments>
		<pubDate>Wed, 21 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Limited</dc:creator>
		
		<category><![CDATA[Art]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[Astellas Pharma Europe Limited]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[September 21]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/international-photographic-exhibition-highlighting-patient-burden-of-neuropathic-pain-opens-at-scientific-conference-50701/</guid>
		<description><![CDATA[STAINES, England, September 21, 2011  -


The Pain Within, a touring exhibition of portraits and images by award-winning photographer Alex Telfer, reveals the untold stories of some of Europe&#8217;speripheral neuropathic pain (PNP) patients
&#8220;I find it incredibly hard to be a mother with neuropathic pain&#8221;&#8230;&#8221;It feels like I&#8217;m being stabbed with a knife over and over again&#8221;&#8230;&#8221;I wasn&#8217;t ... <a href="http://pr.gaeatimes.com/international-photographic-exhibition-highlighting-patient-burden-of-neuropathic-pain-opens-at-scientific-conference-50701/">Original source on Gaea Times at  : International Photographic Exhibition Highlighting Patient Burden of Neuropathic Pain Opens at Scientific Conference</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/international-photographic-exhibition-highlighting-patient-burden-of-neuropathic-pain-opens-at-scientific-conference-50701/feed/</wfw:commentRss>
		</item>
		<item>
		<title>New International Photographic Exhibition Makes Visible the Hidden Agony of Peripheral Neuropathic Pain</title>
		<link>http://pr.gaeatimes.com/new-international-photographic-exhibition-makes-visible-the-hidden-agony-of-peripheral-neuropathic-pain-50702/</link>
		<comments>http://pr.gaeatimes.com/new-international-photographic-exhibition-makes-visible-the-hidden-agony-of-peripheral-neuropathic-pain-50702/#comments</comments>
		<pubDate>Wed, 21 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Limited</dc:creator>
		
		<category><![CDATA[Art]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[Astellas Pharma Europe Limited]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[September 21]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/new-international-photographic-exhibition-makes-visible-the-hidden-agony-of-peripheral-neuropathic-pain-50702/</guid>
		<description><![CDATA[STAINES, England, September 21, 2011  -


- The Pain Within, a touring exhibition of portraits and images by award-winning photographer Alex Telfer, reveals the untold stories of some of Europe&#8217;speripheral neuropathic pain (PNP) patients
&#8220;I find it incredibly hard to be a mother with neuropathic pain&#8221;&#8230;&#8221;It feels like I&#8217;m being stabbed with a knife over and over again&#8221;&#8230;&#8221;I ... Read the original article on Gaea Times at  : <a href="http://pr.gaeatimes.com/new-international-photographic-exhibition-makes-visible-the-hidden-agony-of-peripheral-neuropathic-pain-50702/">New International Photographic Exhibition Makes Visible the Hidden Agony of Peripheral Neuropathic Pain</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/new-international-photographic-exhibition-makes-visible-the-hidden-agony-of-peripheral-neuropathic-pain-50702/feed/</wfw:commentRss>
		</item>
		<item>
		<title>World-leading Biomedical Engineer, Dr Robert Langer, to Receive Economist Innovation Award Sponsored by Astellas Pharma Europe Ltd.</title>
		<link>http://pr.gaeatimes.com/world-leading-biomedical-engineer-dr-robert-langer-to-receive-economist-innovation-award-sponsored-by-astellas-pharma-europe-ltd-50741/</link>
		<comments>http://pr.gaeatimes.com/world-leading-biomedical-engineer-dr-robert-langer-to-receive-economist-innovation-award-sponsored-by-astellas-pharma-europe-ltd-50741/#comments</comments>
		<pubDate>Wed, 21 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Limited</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Media]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe Limited]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[September 21]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/world-leading-biomedical-engineer-dr-robert-langer-to-receive-economist-innovation-award-sponsored-by-astellas-pharma-europe-ltd-50741/</guid>
		<description><![CDATA[STAINES, England, September 21, 2011  -

Astellas Pharma Europe Ltd. announced today that one of the world&#8217;s most influential biomedical engineers, Dr Robert Langer - the man responsible for founding the field of controlled-release drug delivery and tissue engineering - is to receive The Economist Innovation 2011 award for Bioscience.
This year marks the 10th anniversary of .... Original article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/world-leading-biomedical-engineer-dr-robert-langer-to-receive-economist-innovation-award-sponsored-by-astellas-pharma-europe-ltd-50741/">World-leading Biomedical Engineer, Dr Robert Langer, to Receive Economist Innovation Award Sponsored by Astellas Pharma Europe Ltd.</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/world-leading-biomedical-engineer-dr-robert-langer-to-receive-economist-innovation-award-sponsored-by-astellas-pharma-europe-ltd-50741/feed/</wfw:commentRss>
		</item>
		<item>
		<title>The Osaka Study Evaluated a Typical European Transplant Population and Showed Similar Efficacy for ADVAGRAF™ and PROGRAF™ in Renal Transplantation at the Same 0.2MG/KG Starting Dose</title>
		<link>http://pr.gaeatimes.com/the-osaka-study-evaluated-a-typical-european-transplant-population-and-showed-similar-efficacy-for-advagraf%e2%84%a2-and-prograf%e2%84%a2-in-renal-transplantation-at-the-same-02mgkg-starting-dose-49851/</link>
		<comments>http://pr.gaeatimes.com/the-osaka-study-evaluated-a-typical-european-transplant-population-and-showed-similar-efficacy-for-advagraf%e2%84%a2-and-prograf%e2%84%a2-in-renal-transplantation-at-the-same-02mgkg-starting-dose-49851/#comments</comments>
		<pubDate>Mon, 05 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Limited</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Surveys / Polls / Research]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[Astellas Pharma Europe Limited]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[September 5]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/the-osaka-study-evaluated-a-typical-european-transplant-population-and-showed-similar-efficacy-for-advagraf%e2%84%a2-and-prograf%e2%84%a2-in-renal-transplantation-at-the-same-02mgkg-starting-dose-49851/</guid>
		<description><![CDATA[STAINES, England, September 5, 2011  -


- Optimizing ImmunoSuppression After Kidney Transplantation with ADVAGRAF (OSAKA) study results presented at the European Society for Organ Transplantation 2011 congress
- Results show non-inferiority of ADVAGRAF vs PROGRAF at the same daily dose in renal transplantation
- Higher starting dose of ADVAGRAF gave no additional efficacy benefits
- The overriding factor ... <a href="http://pr.gaeatimes.com/the-osaka-study-evaluated-a-typical-european-transplant-population-and-showed-similar-efficacy-for-advagraf%e2%84%a2-and-prograf%e2%84%a2-in-renal-transplantation-at-the-same-02mgkg-starting-dose-49851/" title="The Osaka Study Evaluated a Typical European Transplant Population and Showed Similar Efficacy for ADVAGRAF™ and PROGRAF™ in Renal Transplantation at the Same 0.2MG/KG Starting Dose">Read more &raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/the-osaka-study-evaluated-a-typical-european-transplant-population-and-showed-similar-efficacy-for-advagraf%e2%84%a2-and-prograf%e2%84%a2-in-renal-transplantation-at-the-same-02mgkg-starting-dose-49851/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas Employees Walk 500 Million Steps to Reach Corporate Health Milestone</title>
		<link>http://pr.gaeatimes.com/astellas-employees-walk-500-million-steps-to-reach-corporate-health-milestone-49727/</link>
		<comments>http://pr.gaeatimes.com/astellas-employees-walk-500-million-steps-to-reach-corporate-health-milestone-49727/#comments</comments>
		<pubDate>Thu, 01 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Limited</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Workforce Management / Human Resources]]></category>

		<category><![CDATA[Astellas Pharma Europe Limited]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[September 1]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/astellas-employees-walk-500-million-steps-to-reach-corporate-health-milestone-49727/</guid>
		<description><![CDATA[STAINES, England, September 1, 2011  -

Employees at Astellas Pharma Europe Ltd. have given themselves a major summer health boost by walking more than 500 million steps - the equivalent of more than eight times around the equator - as part of the world&#8217;s largest corporate health initiative, the Global Corporate Challenge (GCC).
Nearly 650 Astellas .... <a href="http://pr.gaeatimes.com/astellas-employees-walk-500-million-steps-to-reach-corporate-health-milestone-49727/" title="Astellas Employees Walk 500 Million Steps to Reach Corporate Health Milestone">Source &nbsp;: Gaea News Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-employees-walk-500-million-steps-to-reach-corporate-health-milestone-49727/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas Pharma Inc.: Announcement of Regulatory Submission for Mirabegron (YM178), a Treatment for Overactive Bladder, in U.S. and Europe</title>
		<link>http://pr.gaeatimes.com/astellas-pharma-inc-announcement-of-regulatory-submission-for-mirabegron-ym178-a-treatment-for-overactive-bladder-in-us-and-europe-49596/</link>
		<comments>http://pr.gaeatimes.com/astellas-pharma-inc-announcement-of-regulatory-submission-for-mirabegron-ym178-a-treatment-for-overactive-bladder-in-us-and-europe-49596/#comments</comments>
		<pubDate>Tue, 30 Aug 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Inc.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Inc.]]></category>

		<category><![CDATA[August 30]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/astellas-pharma-inc-announcement-of-regulatory-submission-for-mirabegron-ym178-a-treatment-for-overactive-bladder-in-us-and-europe-49596/</guid>
		<description><![CDATA[STAINES, England, August 30, 2011  -

Astellas Pharma Inc. (Tokyo:4503, &#8220;Astellas&#8221;) today announced the submission of a New Drug Application and Market Authorisation Application for mirabegron (generic name / code name: YM178) to the U.S. Food and Drug Administration and the European Medicines Agency. The submissions were sent on August 24 and 26, 2011 (Europe ... Read more : <a href="http://pr.gaeatimes.com/astellas-pharma-inc-announcement-of-regulatory-submission-for-mirabegron-ym178-a-treatment-for-overactive-bladder-in-us-and-europe-49596/">Astellas Pharma Inc.: Announcement of Regulatory Submission for Mirabegron (YM178), a Treatment for Overactive Bladder, in U.S. and Europe</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-pharma-inc-announcement-of-regulatory-submission-for-mirabegron-ym178-a-treatment-for-overactive-bladder-in-us-and-europe-49596/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas Receives Positive Opinion From CHMP for European Approval of VIBATIV(TM) for Nosocomial Pneumonia Caused by MRSA</title>
		<link>http://pr.gaeatimes.com/astellas-receives-positive-opinion-from-chmp-for-european-approval-of-vibativtm-for-nosocomial-pneumonia-caused-by-mrsa-45489/</link>
		<comments>http://pr.gaeatimes.com/astellas-receives-positive-opinion-from-chmp-for-european-approval-of-vibativtm-for-nosocomial-pneumonia-caused-by-mrsa-45489/#comments</comments>
		<pubDate>Fri, 20 May 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Ltd.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe Ltd.]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[May 20]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/astellas-receives-positive-opinion-from-chmp-for-european-approval-of-vibativtm-for-nosocomial-pneumonia-caused-by-mrsa-45489/</guid>
		<description><![CDATA[New Treatment Option for Adult Patients With Nosocomial Pneumonia, Including Critically ill Patients With Ventilator Associated Pneumonia

STAINES, England, May 20, 2011  - Astellas Pharma Europe Ltd., announced today that the Committee for
Medicinal Products for Human Use (CHMP) of the European Medicines Agency
(EMA) adopted a positive opinion, recommending the granting of marketing
authorisation for VIBATIV (telavancin .... Source article &nbsp;: <a href="http://pr.gaeatimes.com/astellas-receives-positive-opinion-from-chmp-for-european-approval-of-vibativtm-for-nosocomial-pneumonia-caused-by-mrsa-45489/">Astellas Receives Positive Opinion From CHMP for European Approval of VIBATIV(TM) for Nosocomial Pneumonia Caused by MRSA</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-receives-positive-opinion-from-chmp-for-european-approval-of-vibativtm-for-nosocomial-pneumonia-caused-by-mrsa-45489/feed/</wfw:commentRss>
		</item>
		<item>
		<title>OSAKA Study Results met Primary Endpoint and Show That Both ADVAGRAF(R) and PROGRAF(TM) Give Similar Results in Renal Transplantation</title>
		<link>http://pr.gaeatimes.com/osaka-study-results-met-primary-endpoint-and-show-that-both-advagrafr-and-prograftm-give-similar-results-in-renal-transplantation-44652/</link>
		<comments>http://pr.gaeatimes.com/osaka-study-results-met-primary-endpoint-and-show-that-both-advagrafr-and-prograftm-give-similar-results-in-renal-transplantation-44652/#comments</comments>
		<pubDate>Mon, 02 May 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Ltd.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe Ltd.]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[May 3]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/osaka-study-results-met-primary-endpoint-and-show-that-both-advagrafr-and-prograftm-give-similar-results-in-renal-transplantation-44652/</guid>
		<description><![CDATA[First Presentation of the Optimizing ImmunoSuppression After Kidney Transplantation with ADVAGRAF (OSAKA) Study Results at American Transplant Congress

STAINES, England, May 3, 2011  - Astellas Pharma Europe Ltd today announced that the results of the
6-month OSAKA study demonstrate that tacrolimus prolonged release (QD;
ADVAGRAF(R), Graceptor(R) in Japan)-based therapy is non-inferior to the same
daily dose of tacrolimus .... <a href="http://pr.gaeatimes.com/osaka-study-results-met-primary-endpoint-and-show-that-both-advagrafr-and-prograftm-give-similar-results-in-renal-transplantation-44652/">Read the original article &nbsp;: OSAKA Study Results met Primary Endpoint and Show That Both ADVAGRAF(R) and PROGRAF(TM) Give Similar Results in Renal Transplantation</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/osaka-study-results-met-primary-endpoint-and-show-that-both-advagrafr-and-prograftm-give-similar-results-in-renal-transplantation-44652/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas Pharma Europe Appoints Ken Jones as President and CEO</title>
		<link>http://pr.gaeatimes.com/astellas-pharma-europe-appoints-ken-jones-as-president-and-ceo-43872/</link>
		<comments>http://pr.gaeatimes.com/astellas-pharma-europe-appoints-ken-jones-as-president-and-ceo-43872/#comments</comments>
		<pubDate>Mon, 11 Apr 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Ltd.</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Personnel Announcements]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[April 11]]></category>

		<category><![CDATA[Astellas Pharma Europe Ltd.]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/astellas-pharma-europe-appoints-ken-jones-as-president-and-ceo-43872/</guid>
		<description><![CDATA[STAINES, England, April 11, 2011  - Astellas Pharma Europe Ltd. (APEL), the European subsidiary of
Tokyo-based Astellas Pharma Inc., one of the world&#39;s top 20 pharmaceutical
companies, today announced the appointment of Ken Jones as its President and
CEO.

    Mr Jones, who since July 2007 has held the position of COO at
Astellas Pharma Europe .... <a href="http://pr.gaeatimes.com/astellas-pharma-europe-appoints-ken-jones-as-president-and-ceo-43872/">Original source &nbsp;: Astellas Pharma Europe Appoints Ken Jones as President and CEO</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-pharma-europe-appoints-ken-jones-as-president-and-ceo-43872/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas and Medivation Announce Initiation of Phase 2 Clinical Trial Comparing MDV3100 With Bicalutamide in Advanced Prostate Cancer</title>
		<link>http://pr.gaeatimes.com/astellas-and-medivation-announce-initiation-of-phase-2-clinical-trial-comparing-mdv3100-with-bicalutamide-in-advanced-prostate-cancer-43379/</link>
		<comments>http://pr.gaeatimes.com/astellas-and-medivation-announce-initiation-of-phase-2-clinical-trial-comparing-mdv3100-with-bicalutamide-in-advanced-prostate-cancer-43379/#comments</comments>
		<pubDate>Wed, 30 Mar 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Ltd.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe Ltd.]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[England And San Francisco]]></category>

		<category><![CDATA[London]]></category>

		<category><![CDATA[March 30]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/astellas-and-medivation-announce-initiation-of-phase-2-clinical-trial-comparing-mdv3100-with-bicalutamide-in-advanced-prostate-cancer-43379/</guid>
		<description><![CDATA[LONDON, STAINES, England and SAN FRANCISCO, March 30, 2011  - Astellas Pharma Europe Ltd. and Medivation, Inc. today announced
treatment of the first patient in the TERRAIN trial, a Phase 2 comparison of
the investigational drug MDV3100, a triple-acting, oral androgen receptor
antagonist, with bicalutamide, a commonly used non-steroidal anti-androgen,
for the treatment of advanced prostate cancer in ... Read more <a href="http://pr.gaeatimes.com/astellas-and-medivation-announce-initiation-of-phase-2-clinical-trial-comparing-mdv3100-with-bicalutamide-in-advanced-prostate-cancer-43379/" title="Astellas and Medivation Announce Initiation of Phase 2 Clinical Trial Comparing MDV3100 With Bicalutamide in Advanced Prostate Cancer">&raquo;&raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-and-medivation-announce-initiation-of-phase-2-clinical-trial-comparing-mdv3100-with-bicalutamide-in-advanced-prostate-cancer-43379/feed/</wfw:commentRss>
		</item>
		<item>
		<title>The Astellas European Foundation Pledges Support to Japan Earthquake Relief</title>
		<link>http://pr.gaeatimes.com/the-astellas-european-foundation-pledges-support-to-japan-earthquake-relief-43171/</link>
		<comments>http://pr.gaeatimes.com/the-astellas-european-foundation-pledges-support-to-japan-earthquake-relief-43171/#comments</comments>
		<pubDate>Thu, 24 Mar 2011 05:00:00 +0000</pubDate>
		<dc:creator>The Astellas European Foundation</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Health Insurance]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Not For Profit]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[March 24]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[The Astellas European Foundation]]></category>

		<category><![CDATA[Tsunami]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/the-astellas-european-foundation-pledges-support-to-japan-earthquake-relief-43171/</guid>
		<description><![CDATA[STAINES, England, March 24, 2011  - The Astellas European Foundation has today announced financial support to
the Japanese Red Cross Society for their work to assist those impacted by the
earthquake and tsunami on Friday, 11th March. The Japanese Red Cross Society
is working with the local government of the affected region and the support
will help provide ... <a href="http://pr.gaeatimes.com/the-astellas-european-foundation-pledges-support-to-japan-earthquake-relief-43171/" title="The Astellas European Foundation Pledges Support to Japan Earthquake Relief">Read more >></a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/the-astellas-european-foundation-pledges-support-to-japan-earthquake-relief-43171/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Peripheral Neuropathic Pain Patients in Sweden set to Benefit From First-of-a-Kind Treatment Which Provides Lasting Pain Relief</title>
		<link>http://pr.gaeatimes.com/peripheral-neuropathic-pain-patients-in-sweden-set-to-benefit-from-first-of-a-kind-treatment-which-provides-lasting-pain-relief-42055/</link>
		<comments>http://pr.gaeatimes.com/peripheral-neuropathic-pain-patients-in-sweden-set-to-benefit-from-first-of-a-kind-treatment-which-provides-lasting-pain-relief-42055/#comments</comments>
		<pubDate>Mon, 28 Feb 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Limited</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe Limited]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[February 28]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[sweden]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/peripheral-neuropathic-pain-patients-in-sweden-set-to-benefit-from-first-of-a-kind-treatment-which-provides-lasting-pain-relief-42055/</guid>
		<description><![CDATA[Decision to Reimburse Qutenza(TM) (capsaicin 8% w/w dermal patch) by Sweden&apos;s Dental and Pharmaceutical Benefits Agency (Tand-och Lakemedelsformansverket) Gives new Option to Patients Living With Difficult-to-Treat Condition

STAINES, England, February 28, 2011  - Patients in Sweden living with peripheral neuropathic pain are set to
gain access to a new treatment option which can provide pain relief ... Read : <a href="http://pr.gaeatimes.com/peripheral-neuropathic-pain-patients-in-sweden-set-to-benefit-from-first-of-a-kind-treatment-which-provides-lasting-pain-relief-42055/">Peripheral Neuropathic Pain Patients in Sweden set to Benefit From First-of-a-Kind Treatment Which Provides Lasting Pain Relief</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/peripheral-neuropathic-pain-patients-in-sweden-set-to-benefit-from-first-of-a-kind-treatment-which-provides-lasting-pain-relief-42055/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas Enters into Partnership With Optimer on Life-Saving Antibiotic Fidaxomicin</title>
		<link>http://pr.gaeatimes.com/astellas-enters-into-partnership-with-optimer-on-life-saving-antibiotic-fidaxomicin-40978/</link>
		<comments>http://pr.gaeatimes.com/astellas-enters-into-partnership-with-optimer-on-life-saving-antibiotic-fidaxomicin-40978/#comments</comments>
		<pubDate>Mon, 07 Feb 2011 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Ltd.</dc:creator>
		
		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe Ltd.]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[February 7]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/astellas-enters-into-partnership-with-optimer-on-life-saving-antibiotic-fidaxomicin-40978/</guid>
		<description><![CDATA[Product Already Filed With European Medicines Agency
STAINES, England, February 7, 2011  - Astellas Pharma Europe Ltd. announced today that it has entered into an
exclusive collaboration and license agreement with Optimer Pharmaceuticals
Inc., San Diego for the development and commercialisation of fidaxomicin, an
investigational antibiotic for Clostridium difficile infection (CDI) in
Europe and certain other countries in the .... Read the original article &nbsp;: <a href="http://pr.gaeatimes.com/astellas-enters-into-partnership-with-optimer-on-life-saving-antibiotic-fidaxomicin-40978/">here</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-enters-into-partnership-with-optimer-on-life-saving-antibiotic-fidaxomicin-40978/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Time Accounting Problems: Isosceles Offers Professional Services Automation (PSA) System Selection and Implementation Service for Time Based Businesses</title>
		<link>http://pr.gaeatimes.com/time-accounting-problems-isosceles-offers-professional-services-automation-psa-system-selection-and-implementation-service-for-time-based-businesses-38086/</link>
		<comments>http://pr.gaeatimes.com/time-accounting-problems-isosceles-offers-professional-services-automation-psa-system-selection-and-implementation-service-for-time-based-businesses-38086/#comments</comments>
		<pubDate>Wed, 17 Nov 2010 05:00:00 +0000</pubDate>
		<dc:creator>Isosceles Finance Ltd</dc:creator>
		
		<category><![CDATA[Accounting]]></category>

		<category><![CDATA[Banking and Financial Services]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Workforce Management / Human Resources]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Isosceles Finance Ltd]]></category>

		<category><![CDATA[November 17]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/time-accounting-problems-isosceles-offers-professional-services-automation-psa-system-selection-and-implementation-service-for-time-based-businesses-38086/</guid>
		<description><![CDATA[STAINES, England, November 17, 2010  - Isosceles Finance, the outsourced accounting and outsourced HR company
expand their services portfolio to include professional services automation
(PSA).

    Isosceles, fed up with so many of their clients developing bespoke
systems or using nothing more than an Excel spreadsheet, have expanded their
service portfolio to include the selection and .... Source article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/time-accounting-problems-isosceles-offers-professional-services-automation-psa-system-selection-and-implementation-service-for-time-based-businesses-38086/">Time Accounting Problems: Isosceles Offers Professional Services Automation (PSA) System Selection and Implementation Service for Time Based Businesses</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/time-accounting-problems-isosceles-offers-professional-services-automation-psa-system-selection-and-implementation-service-for-time-based-businesses-38086/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Isosceles Finance Shortlisted for Accountancy Age Award</title>
		<link>http://pr.gaeatimes.com/isosceles-finance-shortlisted-for-accountancy-age-award-34586/</link>
		<comments>http://pr.gaeatimes.com/isosceles-finance-shortlisted-for-accountancy-age-award-34586/#comments</comments>
		<pubDate>Mon, 13 Sep 2010 05:00:00 +0000</pubDate>
		<dc:creator>Isosceles Finance Ltd</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Banking and Financial Services]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Environment]]></category>

		<category><![CDATA[Green Technology]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Outsourcing Businesses]]></category>

		<category><![CDATA[Workforce Management / Human Resources]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Isosceles Finance Ltd]]></category>

		<category><![CDATA[September 13]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/isosceles-finance-shortlisted-for-accountancy-age-award-34586/</guid>
		<description><![CDATA[Isosceles Finance, the Outsourced Accounting and Outsourced HR Company are Announced as Finalists for the Accountancy Age Award &apos;Small Firm of the Year&apos;

STAINES, England, September 13, 2010  - Isosceles are today celebrating reaching the finalist stage for an
Accountancy Age Award for the third consecutive year. Having narrowly missed
out on the &#39;Best Use of the .... <a href="http://pr.gaeatimes.com/isosceles-finance-shortlisted-for-accountancy-age-award-34586/">Original article on Gaea Times at  &nbsp;: Isosceles Finance Shortlisted for Accountancy Age Award</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/isosceles-finance-shortlisted-for-accountancy-age-award-34586/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Isosceles Finance Extend Existing Outsourced Finance, Accounting and Payroll Services to Include Outsourced HR Management</title>
		<link>http://pr.gaeatimes.com/isosceles-finance-extend-existing-outsourced-finance-accounting-and-payroll-services-to-include-outsourced-hr-management-12595/</link>
		<comments>http://pr.gaeatimes.com/isosceles-finance-extend-existing-outsourced-finance-accounting-and-payroll-services-to-include-outsourced-hr-management-12595/#comments</comments>
		<pubDate>Wed, 03 Feb 2010 05:00:00 +0000</pubDate>
		<dc:creator>Isosceles Finance Ltd</dc:creator>
		
		<category><![CDATA[Banking and Financial Services]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Corporate Expansion]]></category>

		<category><![CDATA[Workforce Management / Human Resources]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Isosceles Finance Ltd]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/isosceles-finance-extend-existing-outsourced-finance-accounting-and-payroll-services-to-include-outsourced-hr-management-12595/</guid>
		<description><![CDATA[STAINES, England, February 3  - In response to growing customer demand Isosceles Finance (
www.isoscelesfinance.co.uk/index.htm), the business accounting and HR
consultants, today introduces their outsourced HR service for small and
medium companies.

    &#34;Quite simply our clients are demanding this service. These most
difficult economic times have generated a raft of HR issues and in volume.
This ... Read more <a href="http://pr.gaeatimes.com/isosceles-finance-extend-existing-outsourced-finance-accounting-and-payroll-services-to-include-outsourced-hr-management-12595/" title="Isosceles Finance Extend Existing Outsourced Finance, Accounting and Payroll Services to Include Outsourced HR Management">&raquo;&raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/isosceles-finance-extend-existing-outsourced-finance-accounting-and-payroll-services-to-include-outsourced-hr-management-12595/feed/</wfw:commentRss>
		</item>
		<item>
		<title>The Astellas European Foundation Supports International Health Partners Relief Work in Haiti</title>
		<link>http://pr.gaeatimes.com/the-astellas-european-foundation-supports-international-health-partners-relief-work-in-haiti-11930/</link>
		<comments>http://pr.gaeatimes.com/the-astellas-european-foundation-supports-international-health-partners-relief-work-in-haiti-11930/#comments</comments>
		<pubDate>Wed, 20 Jan 2010 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe Limited</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[European Government]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe Limited]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Haiti]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/the-astellas-european-foundation-supports-international-health-partners-relief-work-in-haiti-11930/</guid>
		<description><![CDATA[STAINES, England, January 20  - In response to the earthquake in Haiti the Astellas European Foundation
(AEF) has announced that it is providing financial support to the
International Health Partners (IHP) to help supply donated medicines for use
in the devastated country. The donation will aid the provision of medicines
to NGOs (non-governmental organisations) and government-run clinics and
hospitals ... Read more <a href="http://pr.gaeatimes.com/the-astellas-european-foundation-supports-international-health-partners-relief-work-in-haiti-11930/" title="The Astellas European Foundation Supports International Health Partners Relief Work in Haiti">>>></a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/the-astellas-european-foundation-supports-international-health-partners-relief-work-in-haiti-11930/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas Pharma Europe Announces CliniClowns a Winner of the Changing Tomorrow 2009 Awards</title>
		<link>http://pr.gaeatimes.com/astellas-pharma-europe-announces-cliniclowns-a-winner-of-the-changing-tomorrow-2009-awards-11008/</link>
		<comments>http://pr.gaeatimes.com/astellas-pharma-europe-announces-cliniclowns-a-winner-of-the-changing-tomorrow-2009-awards-11008/#comments</comments>
		<pubDate>Tue, 22 Dec 2009 05:00:00 +0000</pubDate>
		<dc:creator>Astellas Pharma Europe</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Staines]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/astellas-pharma-europe-announces-cliniclowns-a-winner-of-the-changing-tomorrow-2009-awards-11008/</guid>
		<description><![CDATA[STAINES, England, December 22  - Astellas Pharma Europe, the European subsidiary of Tokyo-based
Astellas Pharma Inc, one of the world&#39;s top 20 pharmaceutical companies, can
today announce the presentation of an Astellas Changing Tomorrow Charity
Award donation to CliniClowns. This is a funding programme designed to award
organisations that help citizens, of all communities realise their full
potential and .... <a href="http://pr.gaeatimes.com/astellas-pharma-europe-announces-cliniclowns-a-winner-of-the-changing-tomorrow-2009-awards-11008/">Source article &nbsp;: Astellas Pharma Europe Announces CliniClowns a Winner of the Changing Tomorrow 2009 Awards</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-pharma-europe-announces-cliniclowns-a-winner-of-the-changing-tomorrow-2009-awards-11008/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas Pharma Europe Announces Save the Children as a Winner of the Changing Tomorrow 2009 Awards</title>
		<link>http://pr.gaeatimes.com/astellas-pharma-europe-announces-save-the-children-as-a-winner-of-the-changing-tomorrow-2009-awards-8714/</link>
		<comments>http://pr.gaeatimes.com/astellas-pharma-europe-announces-save-the-children-as-a-winner-of-the-changing-tomorrow-2009-awards-8714/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Not For Profit]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe Limited]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/astellas-pharma-europe-announces-save-the-children-as-a-winner-of-the-changing-tomorrow-2009-awards-8714/</guid>
		<description><![CDATA[STAINES, England - Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma Inc, one of the world&#8217;s top 20 pharmaceutical companies, can today announce details of an Astellas Changing Tomorrow Charity Award for Save the Children. The charity award is a funding programme designed to award organisations that help citizens, of all communities, realise .... <a href="http://pr.gaeatimes.com/astellas-pharma-europe-announces-save-the-children-as-a-winner-of-the-changing-tomorrow-2009-awards-8714/">Source article on Gaea Times at  &nbsp;: Astellas Pharma Europe Announces Save the Children as a Winner of the Changing Tomorrow 2009 Awards</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-pharma-europe-announces-save-the-children-as-a-winner-of-the-changing-tomorrow-2009-awards-8714/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas Pharma Europe Announces the International Foundation for Dermatology a Winner of the Changing Tomorrow 2009 Awards</title>
		<link>http://pr.gaeatimes.com/astellas-pharma-europe-announces-the-international-foundation-for-dermatology-a-winner-of-the-changing-tomorrow-2009-awards-8434/</link>
		<comments>http://pr.gaeatimes.com/astellas-pharma-europe-announces-the-international-foundation-for-dermatology-a-winner-of-the-changing-tomorrow-2009-awards-8434/#comments</comments>
		<pubDate>Tue, 03 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe Limited]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Staines]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/astellas-pharma-europe-announces-the-international-foundation-for-dermatology-a-winner-of-the-changing-tomorrow-2009-awards-8434/</guid>
		<description><![CDATA[STAINES, England - Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma Inc, one of the world&#8217;s top 20 pharmaceutical companies, can today announce details of an Astellas Changing Tomorrow Charity Award for the International Foundation for Dermatology. The charity award is a funding programme designed to award organisations that help citizens, of all ... Read more : <a href="http://pr.gaeatimes.com/astellas-pharma-europe-announces-the-international-foundation-for-dermatology-a-winner-of-the-changing-tomorrow-2009-awards-8434/">Astellas Pharma Europe Announces the International Foundation for Dermatology a Winner of the Changing Tomorrow 2009 Awards</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-pharma-europe-announces-the-international-foundation-for-dermatology-a-winner-of-the-changing-tomorrow-2009-awards-8434/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Isosceles Finance Become Accountancy Age Award Finalist for Second Consecutive Year!</title>
		<link>http://pr.gaeatimes.com/isosceles-finance-become-accountancy-age-award-finalist-for-second-consecutive-year-6530/</link>
		<comments>http://pr.gaeatimes.com/isosceles-finance-become-accountancy-age-award-finalist-for-second-consecutive-year-6530/#comments</comments>
		<pubDate>Thu, 24 Sep 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Accounting]]></category>

		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Banking and Financial Services]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Isosceles Finance Ltd]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/isosceles-finance-become-accountancy-age-award-finalist-for-second-consecutive-year-6530/</guid>
		<description><![CDATA[STAINES, England - 
- Isosceles Finance, the Business Accounting Consultants Have Been Announced as Finalists for the Accountancy Age Award &#8216;Small Firm of the Year&#8217;

Isosceles are today celebrating reaching the finalist stage for an Accountancy Age Award for the second consecutive year. Last year they narrowly missed out on the &#8216;Best Use of the Internet ... Read : <a href="http://pr.gaeatimes.com/isosceles-finance-become-accountancy-age-award-finalist-for-second-consecutive-year-6530/">Isosceles Finance Become Accountancy Age Award Finalist for Second Consecutive Year!</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/isosceles-finance-become-accountancy-age-award-finalist-for-second-consecutive-year-6530/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas Pharma Europe Announces Winners of the Changing Tomorrow 2009 Awards</title>
		<link>http://pr.gaeatimes.com/astellas-pharma-europe-announces-winners-of-the-changing-tomorrow-2009-awards-6454/</link>
		<comments>http://pr.gaeatimes.com/astellas-pharma-europe-announces-winners-of-the-changing-tomorrow-2009-awards-6454/#comments</comments>
		<pubDate>Wed, 23 Sep 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Not For Profit]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Astellas Pharma Europe Limited]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/astellas-pharma-europe-announces-winners-of-the-changing-tomorrow-2009-awards-6454/</guid>
		<description><![CDATA[STAINES, England - Astellas Pharma Europe Ltd., the European subsidiary of Tokyo-based Astellas Pharma Inc., one of the world&#8217;s top 20 pharmaceutical companies, has today announced the launch of the Astellas Changing Tomorrow Charity Awards. The charity award funding programme is designed to award organisations that help citizens of all communities realise their full potential .... <a href="http://pr.gaeatimes.com/astellas-pharma-europe-announces-winners-of-the-changing-tomorrow-2009-awards-6454/">Original source &nbsp;: Astellas Pharma Europe Announces Winners of the Changing Tomorrow 2009 Awards</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/astellas-pharma-europe-announces-winners-of-the-changing-tomorrow-2009-awards-6454/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Audio Visual Machines Certified as Platinum Partner and Accredited Service Provider for TANDBERG</title>
		<link>http://pr.gaeatimes.com/audio-visual-machines-certified-as-platinum-partner-and-accredited-service-provider-for-tandberg-3876/</link>
		<comments>http://pr.gaeatimes.com/audio-visual-machines-certified-as-platinum-partner-and-accredited-service-provider-for-tandberg-3876/#comments</comments>
		<pubDate>Tue, 07 Jul 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Telecommunications]]></category>

		<category><![CDATA[Telecommunications Equipment]]></category>

		<category><![CDATA[Audio Visual Machines Ltd]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[New York]]></category>

		<category><![CDATA[Nhs]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/audio-visual-machines-certified-as-platinum-partner-and-accredited-service-provider-for-tandberg-3876/</guid>
		<description><![CDATA[STAINES, England - TANDBERG (OSL:TAA), the leading global provider of telepresence, high-definition video conferencing and mobile video products and services, today announced that Audio Visual Machines (AVM), a leading provider of video and audio communications, has been certified as a TANDBERG Platinum Partner. The Platinum Partner status awarded by TANDBERG is the highest level of ... Read more : <a href="http://pr.gaeatimes.com/audio-visual-machines-certified-as-platinum-partner-and-accredited-service-provider-for-tandberg-3876/">Audio Visual Machines Certified as Platinum Partner and Accredited Service Provider for TANDBERG</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/audio-visual-machines-certified-as-platinum-partner-and-accredited-service-provider-for-tandberg-3876/feed/</wfw:commentRss>
		</item>
		<item>
		<title>The Astellas European Foundation Announces Winner of the 2009 Urology Prize Fund</title>
		<link>http://pr.gaeatimes.com/the-astellas-european-foundation-announces-winner-of-the-2009-urology-prize-fund-525/</link>
		<comments>http://pr.gaeatimes.com/the-astellas-european-foundation-announces-winner-of-the-2009-urology-prize-fund-525/#comments</comments>
		<pubDate>Tue, 24 Mar 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[France]]></category>

		<category><![CDATA[Staines]]></category>

		<category><![CDATA[sweden]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/the-astellas-european-foundation-announces-winner-of-the-2009-urology-prize-fund-525/</guid>
		<description><![CDATA[STAINES, England - On Thursday 19th March 2009, at a ceremony held at the 24th annual EAU
congress in Stockholm, Sweden, the Astellas European Foundation announced the
winner of the 2009 Urology Prize. Dr Wouter Everaerts, MD and his team from
the KU Leuven, Belgium were awarded the prize in the amount of US$ 300,000 to
support their work .... <a href="http://pr.gaeatimes.com/the-astellas-european-foundation-announces-winner-of-the-2009-urology-prize-fund-525/">Source article on Gaea Times at  &nbsp;: The Astellas European Foundation Announces Winner of the 2009 Urology Prize Fund</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/the-astellas-european-foundation-announces-winner-of-the-2009-urology-prize-fund-525/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

